Pesquisar
Galmed Pharmaceuticals Ltd
GLMDAdicionar à lista de desejos
0.570USD
-0.079-12.34%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
3.75MValor de mercado
PerdaP/L TTM
Mais detalhes de Galmed Pharmaceuticals Ltd Empresa
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.
Informações de Galmed Pharmaceuticals Ltd
Código da empresaGLMD
Nome da EmpresaGalmed Pharmaceuticals Ltd
Data de listagemMar 13, 2014
CEOBaharaff (Allen)
Número de funcionários3
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 13
Endereço16 Tiomkin Street
CidadeTEL AVIV-YAFO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal6578317
Telefone97236938448
Sitehttps://www.galmedpharma.com
Código da empresaGLMD
Data de listagemMar 13, 2014
CEOBaharaff (Allen)
Executivos da empresa Galmed Pharmaceuticals Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Allen Baharaff
Mr. Allen Baharaff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
127.23K
+70.97%
Mr. Yohai Stenzler, CPA
Mr. Yohai Stenzler, CPA
Chief Accounting Officer
Chief Accounting Officer
27.95K
+77.52%
Mr. Guy Nehemya
Mr. Guy Nehemya
Chief Operating Officer, Data Protection Officer
Chief Operating Officer, Data Protection Officer
27.95K
+77.52%
Mr. Doron Cohen
Mr. Doron Cohen
Chief Financial Officer
Chief Financial Officer
27.92K
+77.61%
Mr. Shmuel Nir
Mr. Shmuel Nir
Independent Director
Independent Director
14.23K
+76.14%
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Lead Independent Director
Lead Independent Director
14.00K
+77.69%
Mr. Amir Poshinski
Mr. Amir Poshinski
Independent Director
Independent Director
13.96K
+77.62%
Dr. Liat Hayardeny, Ph.D.
Dr. Liat Hayardeny, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Carol L. Brosgart, M.D.
Dr. Carol L. Brosgart, M.D.
Independent Director
Independent Director
--
--
Mr. Marshall A. Heinberg, J.D.
Mr. Marshall A. Heinberg, J.D.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Allen Baharaff
Mr. Allen Baharaff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
127.23K
+70.97%
Mr. Yohai Stenzler, CPA
Mr. Yohai Stenzler, CPA
Chief Accounting Officer
Chief Accounting Officer
27.95K
+77.52%
Mr. Guy Nehemya
Mr. Guy Nehemya
Chief Operating Officer, Data Protection Officer
Chief Operating Officer, Data Protection Officer
27.95K
+77.52%
Mr. Doron Cohen
Mr. Doron Cohen
Chief Financial Officer
Chief Financial Officer
27.92K
+77.61%
Mr. Shmuel Nir
Mr. Shmuel Nir
Independent Director
Independent Director
14.23K
+76.14%
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Lead Independent Director
Lead Independent Director
14.00K
+77.69%
Perguntas frequentes
Quem são os cinco principais acionistas de Galmed Pharmaceuticals Ltd?
Os cinco principais acionistas de Galmed Pharmaceuticals Ltd são: Mr. Allen Baharaff
Quantas instituições possuem ações da Galmed Pharmaceuticals Ltd (GLMD)?
Em 2026Q1, 30 instituições possuíam ações da Galmed Pharmaceuticals Ltd, com valor de mercado aproximado de 224.38K, representando 3.40% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 75169.00.